Somatic symptoms in treatment-resistant depression

George I. Papakostas; Timothy Petersen; John Denninger; Shamsah B. Sonawalla; Yasmin Mahal; Jonathan E. Alpert; Andrew A. Nierenberg; Maurizio Fava

doi:10.1016/S0165-1781(03)00063-5

Somatic symptoms in treatment-resistant depression

George I. Papakostas, Timothy Petersen, John Denninger, Shamsah B. Sonawalla, Yasmin Mahal, Jonathan E. Alpert, Andrew A. Nierenberg, Maurizio Fava

Research output: Contribution to journal › Article

44 Scopus citations

Abstract

The purpose of this work was to study the prevalence of somatic symptoms in patients with treatment-resistant depression (TRD) and their impact on the response to antidepressant treatment. Somatic symptoms were assessed during the screen visit with the Symptom Questionnaire (SQ) somatic symptom (SQ-SS) and somatic well-being sub-scales (SQ-SWB) in 40 patients with TRD enrolled in a 6-week open trial of nortriptyline. A logistic regression was used to test whether SQ-SS or SQ-SWB scores predicted clinical response to nortriptyline. Ninety-five percent of patients reported at least one somatic symptom. Higher SQ-SS scores during the screen visit predicted poorer response to nortriptyline. There was a trend for lower SQ-SWB scores to predict poor response to nortriptyline. None of the patients with SQ-SS scores above the mean for the sample responded to nortriptyline. The overwhelming majority of patients with TRD presented with somatic symptoms. In addition, a greater number of somatic symptoms during the screen visit placed patients at risk for further treatment resistance.

Original language	English (US)
Pages (from-to)	39-45
Number of pages	7
Journal	Psychiatry Research
Volume	118
Issue number	1
DOIs	https://doi.org/10.1016/S0165-1781(03)00063-5
State	Published - May 1 2003
Externally published	Yes

Keywords

Antidepressants
Nortriptyline
Response prediction
Symptom Questionnaire

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1016/S0165-1781(03)00063-5

Fingerprint Dive into the research topics of 'Somatic symptoms in treatment-resistant depression'. Together they form a unique fingerprint.

Cite this

Papakostas, G. I., Petersen, T., Denninger, J., Sonawalla, S. B., Mahal, Y., Alpert, J. E., Nierenberg, A. A., & Fava, M. (2003). Somatic symptoms in treatment-resistant depression. Psychiatry Research, 118(1), 39-45. https://doi.org/10.1016/S0165-1781(03)00063-5

@article{a87b5a017ba14dddbd293f3ab3b1d384,

title = "Somatic symptoms in treatment-resistant depression",

abstract = "The purpose of this work was to study the prevalence of somatic symptoms in patients with treatment-resistant depression (TRD) and their impact on the response to antidepressant treatment. Somatic symptoms were assessed during the screen visit with the Symptom Questionnaire (SQ) somatic symptom (SQ-SS) and somatic well-being sub-scales (SQ-SWB) in 40 patients with TRD enrolled in a 6-week open trial of nortriptyline. A logistic regression was used to test whether SQ-SS or SQ-SWB scores predicted clinical response to nortriptyline. Ninety-five percent of patients reported at least one somatic symptom. Higher SQ-SS scores during the screen visit predicted poorer response to nortriptyline. There was a trend for lower SQ-SWB scores to predict poor response to nortriptyline. None of the patients with SQ-SS scores above the mean for the sample responded to nortriptyline. The overwhelming majority of patients with TRD presented with somatic symptoms. In addition, a greater number of somatic symptoms during the screen visit placed patients at risk for further treatment resistance.",

keywords = "Antidepressants, Nortriptyline, Response prediction, Symptom Questionnaire",

author = "Papakostas, {George I.} and Timothy Petersen and John Denninger and Sonawalla, {Shamsah B.} and Yasmin Mahal and Alpert, {Jonathan E.} and Nierenberg, {Andrew A.} and Maurizio Fava",

year = "2003",

month = may,

day = "1",

doi = "10.1016/S0165-1781(03)00063-5",

language = "English (US)",

volume = "118",

pages = "39--45",

journal = "Psychiatry Research",

issn = "0165-1781",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Somatic symptoms in treatment-resistant depression

AU - Papakostas, George I.

AU - Petersen, Timothy

AU - Denninger, John

AU - Sonawalla, Shamsah B.

AU - Mahal, Yasmin

AU - Alpert, Jonathan E.

AU - Nierenberg, Andrew A.

AU - Fava, Maurizio

PY - 2003/5/1

Y1 - 2003/5/1

N2 - The purpose of this work was to study the prevalence of somatic symptoms in patients with treatment-resistant depression (TRD) and their impact on the response to antidepressant treatment. Somatic symptoms were assessed during the screen visit with the Symptom Questionnaire (SQ) somatic symptom (SQ-SS) and somatic well-being sub-scales (SQ-SWB) in 40 patients with TRD enrolled in a 6-week open trial of nortriptyline. A logistic regression was used to test whether SQ-SS or SQ-SWB scores predicted clinical response to nortriptyline. Ninety-five percent of patients reported at least one somatic symptom. Higher SQ-SS scores during the screen visit predicted poorer response to nortriptyline. There was a trend for lower SQ-SWB scores to predict poor response to nortriptyline. None of the patients with SQ-SS scores above the mean for the sample responded to nortriptyline. The overwhelming majority of patients with TRD presented with somatic symptoms. In addition, a greater number of somatic symptoms during the screen visit placed patients at risk for further treatment resistance.

AB - The purpose of this work was to study the prevalence of somatic symptoms in patients with treatment-resistant depression (TRD) and their impact on the response to antidepressant treatment. Somatic symptoms were assessed during the screen visit with the Symptom Questionnaire (SQ) somatic symptom (SQ-SS) and somatic well-being sub-scales (SQ-SWB) in 40 patients with TRD enrolled in a 6-week open trial of nortriptyline. A logistic regression was used to test whether SQ-SS or SQ-SWB scores predicted clinical response to nortriptyline. Ninety-five percent of patients reported at least one somatic symptom. Higher SQ-SS scores during the screen visit predicted poorer response to nortriptyline. There was a trend for lower SQ-SWB scores to predict poor response to nortriptyline. None of the patients with SQ-SS scores above the mean for the sample responded to nortriptyline. The overwhelming majority of patients with TRD presented with somatic symptoms. In addition, a greater number of somatic symptoms during the screen visit placed patients at risk for further treatment resistance.

KW - Antidepressants

KW - Nortriptyline

KW - Response prediction

KW - Symptom Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=0037621668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037621668&partnerID=8YFLogxK

U2 - 10.1016/S0165-1781(03)00063-5

DO - 10.1016/S0165-1781(03)00063-5

M3 - Article

C2 - 12759160

AN - SCOPUS:0037621668

VL - 118

SP - 39

EP - 45

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1

ER -